Ligand Pharmaceuticals traded at $101.97 this Thursday August 11th, decreasing $4.12 or 3.88 percent since the previous trading session. Looking back, over the last four weeks, Ligand Pharmaceuticals lost 7.28 percent. Over the last 12 months, its price fell by 6.49 percent. Looking ahead, we forecast Ligand Pharmaceuticals to be priced at 94.44 by the end of this quarter and at 86.81 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acorda Therapeutics 0.46 0.02 4.77% -87.12%
Agenus 2.67 0 0% -55.13%
Amgen 248.35 -3.74 -1.48% 8.85%
Anika Therapeutics 21.74 -1.26 -5.48% -46.57%
Arrowhead Research 45.63 -1.33 -2.83% -23.68%
Baxter International 59.97 0.07 0.12% -18.81%
Bristol-Myers Squibb 74.46 -0.40 -0.53% 10.29%
Clovis Oncology 1.45 -0.11 -7.05% -70.41%
Endo International 0.39 -0.04 -8.85% -90.48%
Enanta Pharmaceuticals 66.49 -1.40 -2.06% 43.98%
Gilead Sciences 62.45 -0.69 -1.09% -12.24%
GlaxoSmithKline 1,400.00 -156.60 -10.06% -5.02%
Glaxosmithkline 35.73 -2.57 -6.71% -13.40%
Heron Therapeutics 4.87 0.17 3.62% -56.98%
Harsco 6.56 0.04 0.61% -66.19%
Immunogen 5.24 -0.07 -1.32% -7.09%
Insmed 26.75 -1.46 -5.18% 11.83%
Ionis Pharmaceuticals 43.44 -2.67 -5.79% 10.51%
Karyopharm Therapeutics 4.96 -0.24 -4.62% 2.90%
Lannett 0.58 0.01 1.39% -87.38%
Ligand Pharmaceuticals 101.97 -4.12 -3.88% -6.49%
Eli Lilly 301.17 -3.44 -1.13% 14.31%
MacroGenics 5.09 0.11 2.21% -79.22%
Merck & Co 88.93 -0.26 -0.29% 15.92%
Pacira 56.26 -0.95 -1.66% -3.55%
Pfizer 48.29 -1.66 -3.32% 2.22%
Rigel Pharmaceuticals 1.40 -0.11 -7.28% -66.10%
Sangamo BioSciences 5.82 -0.03 -0.51% -43.00%
Spectrum Pharmaceuticals 1.21 0.09 8.04% -48.51%
Teva Pharmaceutical Industries 11.09 -0.11 -0.98% 11.01%
Veracyte 25.49 -0.47 -1.81% -40.05%
Intrexon 2.32 -0.10 -4.13% -62.09%

Indexes Price Day Year
USND 12780 -74.89 -0.58% -13.74%
US400 2576 15.21 0.59% -5.91%

Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company. The Company is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's technology includes Captisol Technology, OmniAb Technologies (OMT), Icagen Ion Channel Technology Platform, Pelican Expression Technology platform and Liver Targeting Prodrug (LTP) Technology to assist companies in their work toward securing prescription drug and biologic approvals. It has partnerships and license agreements with over 130 pharmaceutical and biotechnology companies and over 300 programs that are in various stages of commercialization, development or research and are fully funded by its collaboration partners and licensees. Its partners and licensees have programs in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.